The Patent Finder

Activatable Cytokine Polypeptides and Methods of Use Thereof (2022)

Werewolf Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 17/741,275, filed May 10, 2022. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,036,266Activatable Cytokine Polypeptides and Methods of Use Thereof
In force
 · Medium confidence
UsedRemaining
EMD Serono, Inc.In forceMedium confidence
US 12,076,371Activatable Cytokine Polypeptides and Methods of Use Thereof
In force
 · Medium confidence
EMD Serono, Inc.In forceMedium confidence
Application 17/741,275Activatable Cytokine Polypeptides and Methods of Use Thereof
Pending
Not granted
EMD Serono, Inc.PendingNot granted
Application 18/764,830Activatable Cytokine Polypeptides and Methods of Use Thereof
Pending
Not granted
EMD Serono, Inc.PendingNot granted
Application 19/242,460Activatable Cytokine Polypeptides and Methods of Use Thereof
Pending
Not granted
EMD Serono, Inc.PendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Werewolf Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited